Table: SymBio Pharmaceuticals - Q1 parent results

SymBio Pharmaceuticals

14/05/2019 07:30

May 14 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2019        Mar 31, 2018      Dec 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             1.61               888 mln            4.47      
                 (+81.4 pct)         (+2.1 pct)        (+16.4 pct)  
  Operating     loss 595 mln        loss 714 mln        loss 3.59   
  Recurring     loss 616 mln        loss 748 mln        loss 3.61   
  Net           loss 616 mln        loss 759 mln        loss 3.62   
  EPS           loss 7.48 yen      loss 13.28 yen    loss 43.88 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T